Intimation of Schedule of Analyst/ Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma Limited has informed the stock exchanges about its upcoming meetings with analysts and institutional investors, as required under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. This is a routine regulatory disclosure made before such interactions take place, and the actual meeting schedule and agenda details would typically be shared through a separate filing. No financial numbers, business updates, or strategic announcements have been disclosed in this particular intimation.
This is a procedural compliance filing and does not, by itself, contain any material information that would directly affect the stock price. Investors should watch for any subsequent disclosures or presentation files shared after the meetings, as those may contain relevant business updates or guidance.